| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/05/2001 | WO2001023590A2 22196, a novel human aminopeptidase |
| 04/05/2001 | WO2001023571A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/05/2001 | WO2001023570A2 Methods and compositions relating to sodium channel beta-1a subunits |
| 04/05/2001 | WO2001023565A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | WO2001023550A2 Pca3 messenger rna species in benign and malignant prostate tissues |
| 04/05/2001 | WO2001023540A2 P-glycoproteins and uses thereof |
| 04/05/2001 | WO2001023425A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | WO2001023405A2 Therapeutic treatment of androgen receptor driven conditions |
| 04/05/2001 | WO2001023399A1 Compounds for the treatment of ischemia |
| 04/05/2001 | WO2001023388A2 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001023387A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022972A2 Immunostimulatory nucleic acids |
| 04/05/2001 | WO2001022970A1 Therapy with 2-5a and interferon |
| 04/05/2001 | WO2001022967A1 Compositions having improved stability |
| 04/05/2001 | WO2001022962A1 Anti-hypercholesterolemic drug combination |
| 04/05/2001 | WO2001022956A2 NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS |
| 04/05/2001 | WO2001022950A2 Diosolane nucleoside analogs for the treatment or prevention of viral infection |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001022936A1 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 04/05/2001 | WO2001022822A1 Method for improving immunity in plants and animals |
| 04/05/2001 | WO2001022820A1 Use of pramipexole as a treatment for cocaine craving |
| 04/05/2001 | WO2001011369A8 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 04/05/2001 | WO2001008657A3 Personal care articles |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000073334A3 Human sorting nexins |
| 04/05/2001 | WO2000072023A3 Diagnosis and treatment of atherosclerosis and coronary heart disease |
| 04/05/2001 | WO2000066713A3 Materials and methods relating to neuronal development |
| 04/05/2001 | WO2000066103A3 Contraceptive compositions containing cyclic urea and amide derivatives |
| 04/05/2001 | WO2000056891A3 Human transmembrane proteins |
| 04/05/2001 | WO2000053738A8 Methods and compositions for regulating memory consolidation |
| 04/05/2001 | WO2000047197A3 Alkylating agents for treatment of cellular proliferation |
| 04/05/2001 | WO2000032805A9 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases |
| 04/05/2001 | WO2000009120A8 New use of taxoid derivatives |
| 04/05/2001 | DE19947235A1 Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten New combination of loteprednol and beta¶2¶-adrenoceptor agonists |
| 04/05/2001 | DE19947234A1 Neue Kombination von Loteprednol und Antihistaminika New combination of loteprednol and antihistamines |
| 04/05/2001 | CA2388484A1 Method for improving immunity in plants and animals |
| 04/05/2001 | CA2388055A1 Immunostimulatory nucleic acids |
| 04/05/2001 | CA2388025A1 Therapy with 2-5a and interferon |
| 04/05/2001 | CA2386095A1 Therapeutic treatment of androgen receptor driven conditions |
| 04/05/2001 | CA2386079A1 Compounds for the treatment of ischemia |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385990A1 Compositions having improved stability |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385743A1 Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis |
| 04/05/2001 | CA2385349A1 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384840A1 Use of pramipexole as a treatment for cocaine craving |
| 04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |
| 04/05/2001 | CA2381771A1 Methods and compositions relating to sodium channel beta1a subunits |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088550A1 alpha-sulfonylamino hydroxamic acid inhibitors of matrix metallo-proteinases for the treatment of peripheral or central nervous system disorders |
| 04/04/2001 | EP1088104A2 Methods for treating a neurological disease by determining bche genotype |
| 04/04/2001 | EP1088100A2 Proteasomal activity |
| 04/04/2001 | EP1088079A2 Nek-related and bub1-related protein kinases |
| 04/04/2001 | EP1088072A2 Prostate cancer-associated genes |
| 04/04/2001 | EP1088069A1 Angiostatin-binding protein |
| 04/04/2001 | EP1088067A1 Methods and compositions for modulating spermatogenesis |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087984A2 acpS |
| 04/04/2001 | EP1087792A1 NrdD |
| 04/04/2001 | EP1087790A2 Use of a compound having affinity for the benzodiazepine mitochondrial receptor in cancer therapy |
| 04/04/2001 | EP1087785A2 Combination of radiotherapy and anti-angiogenic factors |
| 04/04/2001 | EP1087783A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF $i(HELICOBACTER PYLORI)-ASSOCIATED DISORDERS |
| 04/04/2001 | EP1087776A1 A process for the treatment of organophosphate poisoning |
| 04/04/2001 | EP1087775A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 04/04/2001 | EP1087756A1 Particulate acellular tissue matrix |
| 04/04/2001 | EP1087747A1 Foaming composition for hair care |
| 04/04/2001 | EP0828489A4 Smoking cessation treatments using naltrexone and related compounds |
| 04/04/2001 | CN1290168A Inhibition of membrane-associated viral replication |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/03/2001 | US6211246 Rapidly absorbed liquid compositions |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 04/03/2001 | US6211230 Antidotes for organophosphorous nerve agents by administering hu-211 |
| 04/03/2001 | US6211212 Drugs with amide and ester groups as enzyme inhibitors |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 04/03/2001 | US6211200 Administering zinc chelated imidazo(4,5-d)imidazole compounds as granulocyte colony stimulating factor agonists |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211191 Integrin receptor antagonists |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211171 Administering tricyclic amitriptyline and desipramine to treat neuropathic pain |
| 04/03/2001 | US6211168 Methods for preparation and use of 1α,24 (S)-dihydroxy vitamin D2 |
| 04/03/2001 | US6211165 Gene expression; binary conjugates |
| 04/03/2001 | US6211161 UDP-N-acetylmuramoyl-l-alanine:D-glutamate ligase (MURD) of staphylococcus aureus |
| 04/03/2001 | US6210974 Compositions and methods for promoting nerve regeneration |
| 04/03/2001 | US6210944 Phosphoribosyl transferase from Staphylococcus aureus |
| 04/03/2001 | US6210926 Activating apoptosis in cell infected with herpes by in vitro administration of agent that inhibits infected cell protein-4 function |
| 04/03/2001 | US6210918 Detecting level of nitric oxide, arginine or citrulline, or activity or expression of nitric oxide synthase, or conversion of nitric oxide to nitrate and nitrite in sample, and comparing to non-laboring pregnant female |
| 04/03/2001 | US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate |
| 04/03/2001 | US6210913 Modulation of integrin-mediated signal transduction |
| 04/03/2001 | US6210742 Emulsions are suited for preparation of food products, personal care products, pharmaceutical products and industrial products |
| 04/03/2001 | US6210706 S (+) Desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |